Table 1.
Evidence supporting a role for immune system activation in human hypertension |
Reference(s) |
---|---|
Restoration of T cell counts in patients with HIV increases the prevalence of hypertension | 77 |
Anti-kidney antibodies are present in the sera of hypertensive patients | 6 |
Immunosuppressive therapy lowers blood pressure in hypertensive patients | 22, 23 |
Proinflammatory cytokines/mediators positively correlate with blood pressure | 10, 11, 18, 78, 79 |
Circulating CD8+ T cells are increased in hypertensive patients | 79 |
Renal lymphocyte infiltration is increased in patients with hypertension | 80, 81 |
Circulating heat shock proteins, known immune modulators, are increased in hypertensive patients | 82, 83 |
Circulating autoantibodies are increased in patients with essential hypertension, refractory hypertension, and preeclampsia | 57–60, 63, 84 |
Immunoadsorption of pathogenic autoantibodies lowers blood pressure in hypertensive patients | 60 |
The prevalence of hypertension is increased in patients with immune-mediated diseases (i.e., systemic lupus, rheumatoid arthritis, psoriasis, scleroderma). | 46, 49, 85, 86 |